Oral apixaban for the treatment of acute venous thromboembolism
Background Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify
the treatment of venous thromboembolism. Methods In this randomized, double-blind study …
the treatment of venous thromboembolism. Methods In this randomized, double-blind study …
[PDF][PDF] Oral Apixaban for the Treatment of Acute Venous Thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus… - N Engl J …, 2013 - chc.med.ufl.edu
ABSTRACT From the Internal and Cardiovascular Medicine–Stroke Unit, University of
Perugia, Perugia, Italy (GA); the Department of Vascular Medicine, Academic Medical …
Perugia, Perugia, Italy (GA); the Department of Vascular Medicine, Academic Medical …
Oral apixaban for the treatment of acute venous thromboembolism.
G Agnelli, H Buller, A Cohen, M Curto… - NEW ENGLAND …, 2013 - research.unipg.it
BACKGROUND: Apixaban, an oral factor Xa inhibitor administered in fixed doses, may
simplify the treatment of venous thromboembolism. METHODS: In this randomized, double …
simplify the treatment of venous thromboembolism. METHODS: In this randomized, double …
Oral apixaban for the treatment of acute venous thromboembolism.
G Agnelli, HR Buller, A Cohen, M Curto… - New England Journal …, 2013 - hal.science
BACKGROUND: Apixaban, an oral factor Xa inhibitor administered in fixed doses, may
simplify the treatment of venous thromboembolism. METHODS: In this randomized, double …
simplify the treatment of venous thromboembolism. METHODS: In this randomized, double …
[PDF][PDF] Oral Apixaban for the Treatment of Acute Venous Thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus… - N Engl J Med, 2013 - Citeseer
ABSTRACT From the Internal and Cardiovascular Medicine–Stroke Unit, University of
Perugia, Perugia, Italy (GA); the Department of Vascular Medicine, Academic Medical …
Perugia, Perugia, Italy (GA); the Department of Vascular Medicine, Academic Medical …
[PDF][PDF] Oral Apixaban for the Treatment of Acute Venous Thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus… - 2013 - portailvasculaire.fr
Results The primary efficacy outcome occurred in 59 of 2609 patients (2.3%) in the apixaban
group, as compared with 71 of 2635 (2.7%) in the conventional-therapy group (relative risk …
group, as compared with 71 of 2635 (2.7%) in the conventional-therapy group (relative risk …
[PDF][PDF] Oral Apixaban for the Treatment of Acute Venous Thromboembolism
G Agnelli, HR Buller, A Cohen, M Curto, AS Gallus… - N Engl J …, 2013 - ar.aburaihan.com
ABSTRACT From the Internal and Cardiovascular Medicine–Stroke Unit, University of
Perugia, Perugia, Italy (GA); the Department of Vascular Medicine, Academic Medical …
Perugia, Perugia, Italy (GA); the Department of Vascular Medicine, Academic Medical …
[引用][C] Oral Apixaban for the Treatment of Acute Venous Thromboembolism
G AGNELLI, HR BULLER, JI WEITZ… - The New England …, 2013 - pascal-francis.inist.fr
Oral Apixaban for the Treatment of Acute Venous Thromboembolism CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …
Oral apixaban for the treatment of acute venous thromboembolism.
G Agnelli, HR Buller, A Cohen, M Curto… - The New England …, 2013 - europepmc.org
Background Apixaban, an oral factor Xa inhibitor administered in fixed doses, may simplify
the treatment of venous thromboembolism. Methods In this randomized, double-blind study …
the treatment of venous thromboembolism. Methods In this randomized, double-blind study …
Oral apixaban for the treatment of acute venous thromboembolism.
G Agnelli, HR Buller, A Cohen, M Curto… - New England Journal …, 2013 - hal.univ-brest.fr
BACKGROUND: Apixaban, an oral factor Xa inhibitor administered in fixed doses, may
simplify the treatment of venous thromboembolism. METHODS: In this randomized, double …
simplify the treatment of venous thromboembolism. METHODS: In this randomized, double …